
|Articles|March 1, 2007
- Volume 0 0
MEDICARE PATIENTS FORCED TO LIMP ALONG WITHOUT VIAGRA
Advertisement
Seniors and other American mencovered by Medicare will no longerreceive Medicare coverage for erectiledysfunction drugs to improve sexualperformance.
The new reimbursement restrictions,which took effect on January 1, excludecoverage for Viagra (sildenafil citrate),Cialis (tadalafil), or Levitra (vardenafilHCl), unless they are prescribed for conditionsunrelated to sexual performance.Estimates by the CongressionalBudget Office suggest that the newMedicare restrictions could save asmuch as $2 billion by 2015.
Articles in this issue
over 19 years ago
HIVover 19 years ago
compounding HOTLINEover 19 years ago
Miller Rises Above with Ambitious Attitudeover 19 years ago
Project AWAREover 19 years ago
Pharmacies' Lawsuit Against PBMs Won on Appealover 19 years ago
E-Rx Innovation Hits Nation's Capital...over 19 years ago
...And E-Rx Is Available to Every Physicianover 19 years ago
Enhanced Messaging Targets Specific Groupsover 19 years ago
Resource Helps Patients Navigate Health Care Environmentover 19 years ago
PDAs Help Pharmacists Deliver The Best Care, AnywhereAdvertisement
Related to this article

BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.

A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.

Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.

American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.

fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.

Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.

A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
Advertisement
Advertisement
Trending on Pharmacy Times
1
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
2
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
3
What the 2025-2030 Dietary Guidelines Mean for Heart Health
4
Pharmacists Key to Lp(a) Counseling and Lipid Optimization
5

